“Leading Nanotechnologies” finances an antiepileptic drug development

“Leading Nanotechnologies”, a venture fund for low-budget projects, financed the development of a new antiepileptic drug. As of today, it’s the first time a fund created with the participation of RUSNANO financed a medical project.

The size of investment per project is not disclosed.